Extracorporeal photopheresis in the treatment of graft-versus-host disease
- Authors: Guz I.V.1,2, Trachtman P.E.1,2
-
Affiliations:
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of Russia
- 1 Samory Mashela St., Moscow, 117198, Russia
- Issue: Vol 11, No 1 (2016)
- Pages: 47-51
- Section: HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Published: 31.03.2016
- URL: https://oncohematology.abvpress.ru/ongm/article/view/181
- DOI: https://doi.org/10.17650/1818-8346-2016-11-1-47-51
- ID: 181
Cite item
Full Text
Abstract
Extracorporeal photopheresis has proved efficacy in the treatment of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation and is an alternative to other treatments. This method is characterized by good tolerability, the lack of age restrictions, minimum of infectious complications compared to increasing immunosuppression. This therapy gives a real improvement
in the quality of life.
About the authors
I. V. Guz
Federal Research Institute of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of Russia; 1 Samory Mashela St., Moscow, 117198, Russia
Author for correspondence.
Email: ilikis@mail.ru
Russian Federation
P. E. Trachtman
Federal Research Institute of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of Russia; 1 Samory Mashela St., Moscow, 117198, RussiaRussian Federation
References
Supplementary files

